{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:14:44Z","timestamp":1793247284921,"version":"4.5.0"},"reference-count":15,"publisher":"Informa UK Limited","issue":"14","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2025,12,6]]},"DOI":"10.1080\/10428194.2025.2560077","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:59:32Z","timestamp":1760525972000},"page":"2728-2732","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Application of the QT nomogram to ECG monitoring of QT prolongation in arsenic trioxide for acute promyelocytic myeloid leukaemia"],"prefix":"10.1080","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3478-1285","authenticated-orcid":false,"given":"Christopher","family":"Martin","sequence":"first","affiliation":[{"name":"Clinical Toxicology Unit, Princess Alexandra Hospital","place":["Brisbane, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Hill","sequence":"additional","affiliation":[{"name":"Clinical Haematology Unit, Princess Alexandra Hospital","place":["Brisbane, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1176-7923","authenticated-orcid":false,"given":"Katherine","family":"Isoardi","sequence":"additional","affiliation":[{"name":"Clinical Toxicology Unit, Princess Alexandra Hospital","place":["Brisbane, Australia"]},{"name":"Faculty of Medicine, University of Queensland","place":["Brisbane, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2003.10.009"},{"key":"e_1_3_4_3_1","volume-title":"Phenasen concentrated solution for infusion product information","author":"Phebra","year":"2019","unstructured":"Phebra. Phenasen concentrated solution for infusion product information. Phebra Pty Ltd; 2019. [accessed 2023 September 24]. https:\/\/www.phebra.com\/wp-content\/uploads\/2018\/10\/Phenasen-PI-V18_final.pdf."},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-01-894980"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2013.51.2913"},{"key":"e_1_3_4_6_1","unstructured":"National Comprehensive Cancer Network. Acute Myeloid Leukaemia (Version 3.2024); 2024. [accessed 2024 September 1]. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1411."},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.073288"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcm072"},{"key":"e_1_3_4_9_1","volume-title":"Acute promyelocytic leukaemia (APML)","author":"Leukaemia Foundation.","year":"2025","unstructured":"Leukaemia Foundation. Acute promyelocytic leukaemia (APML). Queensland: Leukaemia Foundation; 2025. https:\/\/www.leukaemia.org.au\/blood-cancer\/types-of-blood-cancer\/leukaemia\/acute-promyelocytic-leukaemia\/."},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8167.2010.01738.x"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2015.003"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2004.08.030"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90654-8"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/20451253221104947"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjquality.u209049.w3670"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.617374"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2025.2560077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T07:30:38Z","timestamp":1765783838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2025.2560077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":15,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,12,6]]}},"alternative-id":["10.1080\/10428194.2025.2560077"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2025.2560077","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}